Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

NCT00121628 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00121628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00121628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
October 31, 2010
Enrollment
184 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer